Ke Geng

Partner

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

pdf

Ke Geng advises Chinese companies in connection with outbound investments and exchange listings in the United States or Hong Kong, as well as the privatization of US or HK listed companies, private equity and venture capital financing, mergers and acquisitions transactions, and general corporate matters. Ke provides client-oriented, proactive, and cost-effective services to companies spanning a wide variety of industries, including healthcare and technology, media, and telecommunications (TMT).

Prior to joining O’Melveny, Ke practiced at another large international law firm.

Languages

  • English
  • Mandarin Chinese

Admissions

Bar Admissions

  • New York

Education

  • Northwestern University School of Law, J.D., 2003 
  • New York University, Ph.D., Biochemistry, 2001
  • Peking University, B.S., 1994

Professional Activities

Author

  • “Should China Provide Intellectual Property Protection for Genetically Modified Animals?” Northwestern Journal of International Law and Business (Winter 2003) 

Offshore Public Offerings

  • Represented Bank of Qingdao (03866.HK) in its US$531 million IPO and listing on the Hong Kong Stock Exchange
  • Represented Shanghai Haohai Biological  (6826.HK) in its US$300 million IPO and listing on the Hong Kong Stock Exchange
  • Represented Credit Suisse and China Renaissance as joint bookrunners in the US$53 million initial public offering and NYSE listing of ADS of Jupai Holdings Limited (NYSE: JP)
  • Represented eHi Car Services (NYSE: EHIC) in its US$120 million IPO and listing on the NYSE 
  • Represented Phoenix Healthcare (01515.HK) in its US$220 million IPO and listing on the Hong Kong Stock Exchange 
  • Represented Credit Suisse and an American multinational banking and financial services holding company as joint bookrunners in the US$110 million IPO and listing on the NYSE of Leju Holdings Ltd. (NYSE: LEJU)
  • Represented Credit Suisse and Goldman Sachs as joint bookrunners in US$138 million IPO of Tarena Technologies Inc. (NASDAQ:TEDU) on the NASDAQ 
  • Represented Morgan Stanley, Credit Suisse and Citigroup as lead underwriters on the US$215 million US IPO of 58.com (NYSE: WUBA) 
  • Represented Hengxing Gold (2303:HK) in its HK$330.4 million (approximately US$47 million) IPO and listing on the Hong Kong Stock Exchange 
  • Represented Montage (NASDAQ: MONT) in its US$70 million IPO and listing on NASDAQ 
  • Represented China Polymetallic Mining Limited (2133.HK) in its US$1.82 billion IPO and listing on the Hong Kong Stock Exchange
  • Represented a leading Chinese Internet television company in its US$233 million IPO and listing on the NYSE 
  • Represented a leading Chinese social network website in its US$743 million IPO and listing on the NYSE 
  • Represented one of the largest contract research organizations in China in its US$87 million IPO and listing on the NYSE 
  • Represented a provider of real estate information and consulting services in its US$248 million IPO and listing on NASDAQ 
  • Represented a leading Fujian-based property developer in its US$210 million IPO and listing on the Hong Kong Stock Exchange 
  • Represented the underwriters of a US$212 million IPO and listing on the NYSE of a leading contract research organization in China 
  • Represented a major Chinese bank in its US$5.4 billion IPO and listing on Hong Kong Stock Exchange and Shanghai Stock Exchange 
  • Represented a major Chinese bank in its US$9.2 billion IPO and listing on Hong Kong Stock Exchange and Shanghai Stock Exchange 
  • Represented a biopharmaceutical company in its IPO and listing on NASDAQ 
  • Represented the underwriters in the IPO of a New York-based real estate investment company 
  • Represented a real estate finance group in its IPO and subsequent debt offering
  • Represented the underwriters in the 144A/Regulation S offering of a New York-based specialty finance company that invests in real estate-related securities and other asset classes
VIEW MORE